Product News

Share this article:
The FDA has granted Caraco Pharmaceutical Laboratories approval for its Abbreviated New Drug Application (ANDA) for Phentermine Hydrochloride Tablets indicated as short-term monotherapy for the management of exogenous obesity. According to IMS data, for the 12 months ended June 2007, Phentermine HCl generic and brand products (Adipex-P) combined had annual sales of approximately $34 million.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.